Literature DB >> 21343145

The STEP study provides a hint that vaccine induction of the right CD8+ T cell responses can facilitate immune control of HIV.

Marcus Altfeld, Philip J Goulder.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21343145      PMCID： PMC3071128          DOI： 10.1093/infdis/jiq119

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  30 in total

Review 1.  Post-step modifications for research on HIV vaccines.

Authors:  Lawrence Corey; M Juliana McElrath; James G Kublin
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

2.  Failure of the Merck HIV vaccine: an uncertain step forward.

Authors:  Merlin L Robb
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

3.  AIDS/HIV. A STEP into darkness or light?

Authors:  John P Moore; P J Klasse; Matthew J Dolan; Sunil K Ahuja
Journal:  Science       Date:  2008-05-09       Impact factor: 47.728

Review 4.  Impact of MHC class I diversity on immune control of immunodeficiency virus replication.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2008-08       Impact factor: 53.106

5.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.

Authors:  M Juliana McElrath; Stephen C De Rosa; Zoe Moodie; Sheri Dubey; Lisa Kierstead; Holly Janes; Olivier D Defawe; Donald K Carter; John Hural; Rama Akondy; Susan P Buchbinder; Michael N Robertson; Devan V Mehrotra; Steven G Self; Lawrence Corey; John W Shiver; Danilo R Casimiro
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

6.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

Authors:  Susan P Buchbinder; Devan V Mehrotra; Ann Duerr; Daniel W Fitzgerald; Robin Mogg; David Li; Peter B Gilbert; Javier R Lama; Michael Marmor; Carlos Del Rio; M Juliana McElrath; Danilo R Casimiro; Keith M Gottesdiener; Jeffrey A Chodakewitz; Lawrence Corey; Michael N Robertson
Journal:  Lancet       Date:  2008-11-13       Impact factor: 79.321

7.  Adaptation of HIV-1 to human leukocyte antigen class I.

Authors:  Yuka Kawashima; Katja Pfafferott; John Frater; Philippa Matthews; Rebecca Payne; Marylyn Addo; Hiroyuki Gatanaga; Mamoru Fujiwara; Atsuko Hachiya; Hirokazu Koizumi; Nozomi Kuse; Shinichi Oka; Anna Duda; Andrew Prendergast; Hayley Crawford; Alasdair Leslie; Zabrina Brumme; Chanson Brumme; Todd Allen; Christian Brander; Richard Kaslow; James Tang; Eric Hunter; Susan Allen; Joseph Mulenga; Songee Branch; Tim Roach; Mina John; Simon Mallal; Anthony Ogwu; Roger Shapiro; Julia G Prado; Sarah Fidler; Jonathan Weber; Oliver G Pybus; Paul Klenerman; Thumbi Ndung'u; Rodney Phillips; David Heckerman; P Richard Harrigan; Bruce D Walker; Masafumi Takiguchi; Philip Goulder
Journal:  Nature       Date:  2009-02-25       Impact factor: 49.962

8.  Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.

Authors:  Jinyan Liu; Kara L O'Brien; Diana M Lynch; Nathaniel L Simmons; Annalena La Porte; Ambryice M Riggs; Peter Abbink; Rory T Coffey; Lauren E Grandpre; Michael S Seaman; Gary Landucci; Donald N Forthal; David C Montefiori; Angela Carville; Keith G Mansfield; Menzo J Havenga; Maria G Pau; Jaap Goudsmit; Dan H Barouch
Journal:  Nature       Date:  2008-11-09       Impact factor: 49.962

Review 9.  HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

Authors:  Klaus Uberla
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

10.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.

Authors:  Paul A Goepfert; Wendy Lumm; Paul Farmer; Philippa Matthews; Andrew Prendergast; Jonathan M Carlson; Cynthia A Derdeyn; Jianming Tang; Richard A Kaslow; Anju Bansal; Karina Yusim; David Heckerman; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2008-04-21       Impact factor: 14.307
View more
  7 in total

1.  Coordinate linkage of HIV evolution reveals regions of immunological vulnerability.

Authors:  Vincent Dahirel; Karthik Shekhar; Florencia Pereyra; Toshiyuki Miura; Mikita Artyomov; Shiv Talsania; Todd M Allen; Marcus Altfeld; Mary Carrington; Darrell J Irvine; Bruce D Walker; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

2.  PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.

Authors:  Jingying Zhou; Allen K L Cheung; Zhiwu Tan; Haibo Wang; Wenbo Yu; Yanhua Du; Yuanxi Kang; Xiaofan Lu; Li Liu; Kwok-Yung Yuen; Zhiwei Chen
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

3.  HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.

Authors:  Henrik N Kloverpris; Anette Stryhn; Mikkel Harndahl; Mary van der Stok; Rebecca P Payne; Philippa C Matthews; Fabian Chen; Lynn Riddell; Bruce D Walker; Thumbi Ndung'u; Søren Buus; Philip Goulder
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

Review 4.  The use of viral vectors in vaccine development.

Authors:  Tatianna Travieso; Jenny Li; Sneha Mahesh; Juliana Da Fonzeca Redenze E Mello; Maria Blasi
Journal:  NPJ Vaccines       Date:  2022-07-04       Impact factor: 9.399

Review 5.  Virus-vectored influenza virus vaccines.

Authors:  Ralph A Tripp; S Mark Tompkins
Journal:  Viruses       Date:  2014-08-07       Impact factor: 5.048

6.  Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.

Authors:  Ellen M Leitman; Jacob Hurst; Masahiko Mori; James Kublin; Thumbi Ndung'u; Bruce D Walker; Jonathan Carlson; Glenda E Gray; Philippa C Matthews; Nicole Frahm; Philip J R Goulder
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

Review 7.  Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19.

Authors:  Kenneth Lundstrom
Journal:  Viruses       Date:  2020-11-18       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.